Story perspectives

Psilocybin Boosts Speech and Mobility in Elderly Alzheimer Patient

6/9/2026

Summary

Woman Improves

An 80-year-old Japanese-American woman with advanced Alzheimer’s showed improvement after a 5-gram psilocybin dose.
Nineteen hours later she spoke spontaneously and regained bladder control.
A 3-gram dose a month later increased her verbal expressivity, humor, facial mimicry, and walking agility.
Researchers said the gains were temporary, urged controlled trials with imaging and biomarkers, and noted U.S. Alzheimer’s cases exceed 7 million, projected to reach nearly 13 million by 2050.

Summary

Researchers Explore Psychedelics

Alzheimer's disease is the most common form of dementia and progressively destroys memory, language, continence, and mobility.
In advanced stages, meaningful functional recovery is generally considered unlikely.
Current therapies at this stage remain largely supportive, managing symptoms without restoring lost abilities.
The therapeutic gap has spurred growing interest in neuromodulatory approaches such as psychedelic compounds.
Researchers propose that psychedelics might temporarily reactivate dormant neural circuits, offering a novel intervention pathway.

1 of 2

Woman Improves

An 80-year-old Japanese-American woman with advanced Alzheimer’s showed improvement after a 5-gram psilocybin dose.
Nineteen hours later she spoke spontaneously and regained bladder control.
A 3-gram dose a month later increased her verbal expressivity, humor, facial mimicry, and walking agility.
Researchers said the gains were temporary, urged controlled trials with imaging and biomarkers, and noted U.S. Alzheimer’s cases exceed 7 million, projected to reach nearly 13 million by 2050.

1 / 2